NEA Management Company’s Oric Pharmaceuticals ORIC Stock Holding History

NEA Management Company’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$44.6M	Hold	4,118,621	–	–	2.81%	11
2026 Q1	$52.2M	Hold	4,118,621	–	–	2.97%	11
2025 Q4	$33.7M	Hold	4,118,621	–	–	1.72%	13
2025 Q3	$49.4M	Hold	4,118,621	–	–	2.71%	13
2025 Q2	$41.8M	Buy	4,118,621 +1,923,076	+88%	+$12.9M	3.15%	8
2025 Q1	$12.3M	Buy	2,195,545 +629,464	+40%	+$5.5M	0.94%	21
2024 Q4	$12.6M	Buy	1,566,081 +66,081	+4%	+$606K	0.71%	21
2024 Q3	$15.4M	Hold	1,500,000	–	–	0.84%	22
2024 Q2	$10.6M	Hold	1,500,000	–	–	0.8%	24
2024 Q1	$20.6M	Buy	+1,500,000	New	+$17.8M	1.28%	19

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

AIHC Capital Management Central $104M AUM

NEA Management Company's ORIC Position: Q2 2026 in Review

NEA Management Company held its Oric Pharmaceuticals (ORIC) position steady in Q2 2026 at 4,118,621 shares worth $44.6M. The position accounts for 2.81% of the portfolio, ranked #11.

NEA Management Company first reported a position in ORIC in Q1 2024 and has held it in 10 quarters since. The position peaked at $52.2M in Q1 2026. 181 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

NEA Management Company held 4,118,621 shares of Oric Pharmaceuticals worth $44.6M as of Q2 2026.
NEA Management Company left its Oric Pharmaceuticals share count unchanged in Q2 2026.
Oric Pharmaceuticals made up 2.81% of NEA Management Company's portfolio in Q2 2026, its #11 holding.
NEA Management Company first reported a position in Oric Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
NEA Management Company's Oric Pharmaceuticals position peaked at $52.2M in Q1 2026.
181 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on NEA Management Company's 13F filing for Q2 2026, filed 14 Aug 2026.